ArticleClinical and experimental medicine2026
Development and validation of a multimodal machine learning prediction model for heart failure after acute myocardial infarction.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 2010-2023.Hepatology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Heart failure after acute myocardial infarction (post-MI HF) has become a major global health problem. Accurate risk prediction is essential for optimising management and preventing post-MI HF. However, existing models rely mainly on resting-state clinical examinations and inadequately reflect the complex pathophysiology of post-MI HF. We aimed to develop and validate a multimodal machine learning (ML) model incorporating cardiopulmonary exercise testing (CPET) data to predict post-MI HF risk and to quantify CPET's incremental value.This study included 3172 acute myocardial infarction (AMI) patients who underwent CPET at three hospitals from 2018 to 2023. The primary outcome was post-MI HF within 1 year. Thirteen ML algorithms were used to select clinical and CPET variables and to construct multimodal prediction models. The incremental predictive value of CPET was evaluated by the area under the curve (AUC), integrated discrimination improvement index (IDI), and net reclassification improvement index (NRI).After screening, 2221 patients were included, of whom 221 (10.0%) developed post-MI HF. The optimal multimodal ML model achieved an AUC of 0.987 (95% CI: 0.982-0.992) in training set and 0.929 (95% CI: 0.903-0.955) in external validation set. Ablation analyses showed that CPET significantly improved discrimination (AUC: 0.890 vs. 0.929, P=0.003), calibration (IDI=0.135 [95% CI: 0.082-0.189], P<0.001), and reclassification (NRI=0.154 [95% CI: 0.073-0.234], P<0.001). The model effectively stratified low- and high-risk patients (3.1% vs. 54.7%, P<0.001). The multimodal ML model accurately predicted post-MI HF and highlighted the additive value of CPET in risk stratification. The web-based risk calculator derived from this model may support early identification of high-risk patients and facilitate personalised management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.